Institutional Ownership Rhythm Pharmaceuticals, Inc. (RYTM)
This table provides information about the institutional ownership of Rhythm Pharmaceuticals, Inc. (RYTM). We have compiled data on the 192 institutions that hold shares in the stock, with a total of 67.3 Million shares, which have been reported (via 13F filing form) to have a value of $4 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
464,604
shares
|
$27.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.32%
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
435,900
shares
|
$26.1 Million
0.54% of portfolio
|
Q3 2024
Reduced 38.16%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
433,866
shares
|
$26 Million
0.0% of portfolio
|
Q3 2024
Added 1.38%
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
406,615
shares
|
$24.4 Million
0.03% of portfolio
|
Q3 2024
Added 280.69%
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
400,000
shares
|
$24 Million
1.47% of portfolio
|
Q3 2024
Reduced 15.79%
|
|
Candriam S.C.A.
|
Nov 13, 2024 Q3 2024 |
395,377
shares
|
$23.7 Million
0.12% of portfolio
|
Q3 2024
Added 45.68%
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
353,323
shares
|
$21.2 Million
0.07% of portfolio
|
Q3 2024
Reduced 23.55%
|
|
National Bank Of Canada
|
Nov 14, 2024 Q3 2024 |
341,507
shares
|
$20.5 Million
0.02% of portfolio
|
Q3 2024
Reduced 15.52%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
329,339
shares
|
$19.7 Million
0.02% of portfolio
|
Q3 2024
Reduced 58.92%
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2024 Q3 2024 |
276,678
shares
|
$16.6 Million
1.37% of portfolio
|
Q3 2024
New holding
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
264,417
shares
|
$15.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.44%
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 12, 2024 Q3 2024 |
259,416
shares
|
$15.5 Million
0.0% of portfolio
|
Q3 2024
Added 11.49%
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
255,578
shares
|
$15.3 Million
3.33% of portfolio
|
Q3 2024
Added 38.4%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
225,373
shares
|
$13.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.68%
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
172,647
shares
|
$10.3 Million
5.24% of portfolio
|
Q4 2023
Reduced 50.0%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
147,875
shares
|
$8.86 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.83%
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
143,823
shares
|
$8.62 Million
0.07% of portfolio
|
Q3 2024
Added 225.05%
|
|
Great Lakes Advisors, LLC
Chicago, IL |
Nov 04, 2024 Q3 2024 |
136,950
shares
|
$8.21 Million
0.06% of portfolio
|
Q3 2024
New holding
|
|
Abrdn PLC
|
Oct 24, 2024 Q3 2024 |
112,804
shares
|
$6.76 Million
0.01% of portfolio
|
Q2 2024
New holding
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
109,186
shares
|
$6.54 Million
0.0% of portfolio
|
Q3 2024
Reduced 25.47%
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
106,397
shares
|
$6.38 Million
0.0% of portfolio
|
Q3 2024
Added 98.39%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
106,250
shares
|
$6.37 Million
0.0% of portfolio
|
Q3 2024
Added 15.44%
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
102,832
shares
|
$6.16 Million
0.01% of portfolio
|
Q3 2024
Added 171.96%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
102,778
shares
|
$6.16 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Nov 14, 2024 Q3 2024 |
102,646
shares
|
$6.15 Million
0.02% of portfolio
|
Q3 2024
Added 0.05%
|